New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 10, 2014
10:00 EDTDRQ, FUEL, PETX, S, FEYE, ACSF, UNT, FFIV, CELPOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: American Capital Senior Floating (ACSF) initiated with an Outperform at Keefe Bruyette... Aratana Therapeutics (PETX) initiated with an Overweight at Barclays... Cypress Energy (CELP) initiated with a Buy at Stifel... FireEye (FEYE) initiated with an Outperform at Wells Fargo... Rocket Fuel (FUEL) initiated with a Buy at Goldman... F5 Networks (FFIV) initiated with a Buy at Dougherty... Hertz (HTZ) initiated with a Neutral at Credit Suisse... Sprint (S) initiated with an Equal Weight at Barclays... Dril-Quip (DRQ) initiated with a Market Perform at Cowen... Unit Corp. (UNT) initiated with a Market Perform at Cowen.
News For ACSF;PETX;CELP;FEYE;FUEL;FFIV;S;DRQ;UNT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
July 29, 2015
06:17 EDTFEYEFireEye upgraded to Outperform from Perform at Oppenheimer
July 28, 2015
06:08 EDTFFIVF5 Networks implied volatility of 25 at lower end of index mean range
Subscribe for More Information
July 27, 2015
11:49 EDTFEYEStocks with call strike movement; FEYE GRPO
Subscribe for More Information
07:18 EDTPETXAratana Therapeutics reports cats weight changes in AT-002 study
Subscribe for More Information
July 24, 2015
09:30 EDTFEYEFireEye downgraded to Mixed from Positive at OTR Global
Subscribe for More Information
July 23, 2015
18:21 EDTFEYE, FFIVOn The Fly: Top stock stories for Thursday
Stocks began the session mixed on the heels of weak earnings reports from both Caterpillar (CAT) and 3M (MMM). The Nasdaq managed to spend most of the day in positive territory but joined the other averages in negative territory by mid-afternoon. Selling picked up momentum towards late afternoon, and by day’s end each of the averages were lower by more than 0.4%, with the Dow losing nearly 0.7%. ECONOMIC EVENTS: In the U.S., initial jobless claims fell to 255,000 in the week ended July 18, below the 278,000 first-time claims that were expected. The Leading Economic Indicators advanced 0.6% in June, exceeding expectations for a 0.3% increase. In Asia, the Shanghai Composite index advanced for a sixth straight session, adding another 2.4%. In Europe, the Greek Parliament voted to accept creditor terms for a new bailout, though a decision on when to reopen Greek financial markets was deferred to next week. COMPANY NEWS: Shares of General Motors (GM) finished the session up 3.96% to $31.50 after reporting earnings per share above analyst expectations. Other notable names rising following earnings reports include SanDisk (SNDK), Under Armour (UA), Southwest (LUV)... Caterpillar, meanwhile, dropped $2.86, or 3.59%, to $76.90 after cutting its yearly guidance during this morning's earnings report, with the company noting a "relatively stagnant" global economy. Also lower following earnings were Comcast (CMCSA, CMCSK), Bristol-Myers Squibb (BMY), Dunkin Brands (DNKN), and Boston Scientific (BSX). MAJOR MOVERS: Among the notable gainers was Cigna (CI), which rose $3.29, or 2.18%, to $154.36 after the Wall Street Journal reported last night that Anthem (ANTM) is nearing a deal to acquire the company for roughly $187, representing a total transaction value of over $48B. Adding to that report, CNBC's David Faber said on Thursday morning that Anthem will announce an agreement Friday to purchase Cigna for $188 per share, at a 45% equity, 55% cash split. Also higher were shares of numerous IT security companies, with FireEye (FEYE) advancing 4.53% and Palo Alto Networks (PANW) adding 2.33% after earnings reports from security firms Fortinet (FTNT) and F5 Networks (FFIV) beat on both top and bottom lines. Fortinet and F5, meanwhile, finished Thursday's session up 10.71% and 7.75% to $46.83 and $127.68, respectively. Among the noteworthy losers following earnings was McDonald's (MCD), which edged down 0.52% to $97.10 after noting that Q2 global comparable sales fell 0.7% for the quarter, including a 2% decline in U.S. same-store sales. Also lower was Hertz (HTZ), which declined 8.53% to $16.45 following a downgrade to Underweight at Morgan Stanley, with the research firm citing increased competition from Uber and similar mobility services. INDEXES: The Dow fell 119.12, or 0.67%, to 17,731.92, the Nasdaq lost 25.36, or 0.49%, to 5,146.41, and the S&P 500 declined 12.00, or 0.57%, to 2,102.15.
14:17 EDTFEYEEarnings Watch: Visa reports after 'top pick' mention by Bernstein
Visa (V) is expected to report third quarter results after the close on July 23, with a conference call scheduled for 5:00 pm ET. Visa is a global payments technology company. EXPECTATIONS: Analysts are looking for earnings per share of 59c on revenue of $3.36B. EPS consensus ranges 54c-65c on a revenue range of $3.32B-$3.41B, according to First Call. LAST QUARTER: On April 30, Visa reported second quarter EPS of 63c against expectations for 62c, and reported revenue of $3.41B versus estimates of $3.34B. During its quarterly conference call, the company noted that "we're now looking at Q3 fully diluted EPS being 6c-8c lower than analyst's current expectations," adding that results are likely to be pressured by higher client incentives. Visa executives also disclosed expectations for a "meaningful step-up" in Q3 expense growth, with a number of marketing and technology initiatives having shifted towards the latter half of the year. PEERS: American Express (AXP) reported quarterly earnings after the close on July 22, with earnings above consensus estimates but revenue somewhat below expectations, noting a "significant" impact from a stronger U.S. dollar on international operations. NEWS: On May 8, Bloomberg reported that Visa was in preliminary talks to acquire Visa Europe for $15B-$20B, according to sources. On June 3, Visa and FireEye (FEYE) announced a strategic partnership to co-develop tools and services to protect against cyber attacks targeting payment data. On June 5, the Wall Street Journal reported that, due to Visa and MasterCard (MA) having finalized their card-security technology, Google's (GOOG) Android Pay will not be earning any transaction fees from credit-card issuers, and on June 17, Reuters reported that a U.S. appeals court affirmed that American Express can no longer block businesses from steering customers towards competitor cards, such as those of Visa. STREET RESEARCH: On May 19, Pacific Crest's Josh Beck shifted his preference to MasterCard from Visa, though he noted that the shift was simply due to Visa's outperformance over the past year. On May 20, Bernstein noted that the risk/reward ratio for both Visa and MasterCard looks positive, with the companies offering secular growth, "compelling" business models, and modest risk. More recently on July 14, Bernstein named Visa among its "Vintage Values 2016" list, citing the company's U.S. acquirer price increase and expectations that the Visa Europe put option will be exercised this year. PRICE ACTION: Shares of Visa have fallen just under 1% to $71.41 ahead of Thursday's earnings report.
11:32 EDTFEYE, FFIVIT security stocks climb after Fortinet, F5 beat expectations
Subscribe for More Information
10:05 EDTFFIVHigh option volume stocks
Subscribe for More Information
07:22 EDTSSprint price target lowered to $3 from $4 at Jefferies
Subscribe for More Information
July 22, 2015
19:02 EDTFFIV, FEYEOn The Fly: After Hours Movers
Subscribe for More Information
17:29 EDTFFIVF5 Networks spikes over 5% after Q3 results, guidance
Subscribe for More Information
16:07 EDTFFIVF5 Networks sees Q4 EPS $1.72-$1.75, consensus $1.71
Subscribe for More Information
16:06 EDTFFIVF5 Networks reports Q3 EPS $1.67, consensus $1.60
Subscribe for More Information
15:26 EDTFFIVNotable companies reporting after market close
Notable companies reporting after the market close, with earnings consensus, include Qualcomm (QCOM), consensus 95... American Express (AXP), consensus $1.32... Texas Instruments (TXN), consensus 65c... Las Vegas Sands (LVS), consensus 61c... Crown Castle (CCI), consensus $1.06... Discover Financial (DFS), consensus $1.32... Tractor Supply (TSCO), consensus $1.11... SanDisk (SNDK), consensus 33c... SL Green Realty (SLG), consensus $1.56... Xilinx (XLNX), consensus 54c... Weatherford (WFT), consensus (12c)... F5 Networks (FFIV), consensus $1.60... United Rentals (URI), consensus $1.74... Fortinet (FTNT), consensus 9c... LaSalle Hotel (LHO), consensus 89c... Oceaneering International (OII), consensus 68c... Cheesecake Factory (CAKE), consensus 62c.
12:42 EDTFFIVF5 Networks technical notes before earnings news
The stock has been trading in a sideways range bound largely by $110 at the low and $128 since January of this year. Those two bounds may help us understand where price could go following earnings news. If the news is bullish, the top of the range is likely to be tested. On a breakout above $128, next resistance levels to watch as potential upside objectives are at $130.86, $132.58, and $136.11 which is the 52-week high. If the news is bearish, the low of the range at $110 could be tested. This area has been strong support going back to May 2014. If there were a breakdown below it, price reactions could be stronger than average. Next supports to watch would be at $106.57, $99.26 and $97.16.
11:34 EDTFFIVOptions with increasing put volume and implied volatility: RSX CLF FFIV
Subscribe for More Information
09:25 EDTPETXAratana Therapeutics updates canine monoclonal antibody product pipeline
Aratana Therapeutics provided an update on the development, manufacturing and commercialization of their monoclonal antibodies targeting canine B-cell lymphoma and canine T-cell lymphoma. AT-004 has received full licensure from the United States Department of Agriculture, and AT-005 has received conditional licensure from the USDA and Aratana continues to anticipate full licensure in 2015. Aratana has completed enrollment in its second designed to assess adding AT-005 to a multi-agent chemotherapy protocol for dogs with T-cell lymphoma. Results from two studies are expected by mid-2016. Aratana continues to make AT-005 commercially available through a T-cell Clinical Experience Program. Aratana expects to report the initial results of B-CEP and the mini B-CHOMP study results in mid-2016. Aratana anticipates that it will remain manufacturing constrained on AT-004 until late-2016. Aratana expects a limited commercialization through the T-CEP and B-CEP programs until late 2016 at which time a full commercial launch is anticipated.
July 20, 2015
10:00 EDTUNTOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:02 EDTUNTUnit Corp. upgraded to Buy from Accumulate at KLR Group
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use